Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - TOTAL OTHER INCOME
Total Other Income DNLI - Denali Therapeutics Inc.
51.5 M
LAST VALUE
234.80%
2 YEAR CAGR
38.43%
5 YEAR CAGR
0.00%
10 YEAR CAGR